Research Articles | Page 14 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome Apr 2023 Blood Cancer Myelodysplastic Syndromes (MDS)
Novel therapeutic choices in immune aplastic anemia Sep 2020 F1000Research Aplastic Anemia
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria Jul 2023 Clinical and Experimental Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment May 2023 The Cancer Journal Myelodysplastic Syndromes (MDS)
Newly revised 2023 MDS response criteria Apr 2023 Blood Myelodysplastic Syndromes (MDS)
New Approaches for Anemia in MDS Sep 2020 Clinical Lymphoma , Myeloma & Leukemia Myelodysplastic Syndromes (MDS)
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes Jun 2023 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Myelodysplastic Syndromes: Moving Towards Personalized Management May 2020 Haematologica Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Nov 2020 Annals of Oncology: Official Journal of the European Society for Medical Oncology Myelodysplastic Syndromes (MDS)